Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PL Thomas & Company Acquires Patent-Pending Indications - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

PL Thomas & Company Acquires Patent-Pending Indications

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

PL Thomas & Company Acquires Patent-Pending Indications
PL Thomas & Company (PLT), Morristown, NJ, has acquired new patent-pending indications for its natural vitamin K2 marketed under the trademark MenaQ7. The role of Natural Vitamin K2 in bone health is well established, and recent research has shown that of the group of K vitamins, only K2 is linked to cardiovascular health. The alliance between PLT, Natto Pharma, Norway, and VitaK BV now allows MenaQ7 to be offered for cardiovascular benefits with proprietary research and U.S. patents pending.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics